Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$0.89 - $2.52 $1,017 - $2,880
-1,143 Reduced 6.87%
15,498 $13,000
Q4 2022

Feb 14, 2023

BUY
$1.02 - $7.48 $190 - $1,398
187 Added 1.14%
16,641 $19,000
Q3 2022

Nov 18, 2022

SELL
$6.04 - $9.66 $6,444 - $10,307
-1,067 Reduced 6.09%
16,454 $124,000
Q2 2022

Aug 15, 2022

BUY
$4.99 - $8.96 $18,747 - $33,662
3,757 Added 27.3%
17,521 $110,000
Q1 2022

May 16, 2022

SELL
$3.84 - $9.74 $13,451 - $34,119
-3,503 Reduced 20.29%
13,764 $114,000
Q3 2021

Nov 15, 2021

SELL
$6.68 - $9.1 $180,005 - $245,217
-26,947 Reduced 60.95%
17,267 $115,000
Q2 2021

Aug 16, 2021

SELL
$7.82 - $9.23 $16,046 - $18,939
-2,052 Reduced 4.44%
44,214 $377,000
Q4 2020

Feb 16, 2021

BUY
$7.98 - $12.29 $37,122 - $57,173
4,652 Added 11.18%
46,266 $569,000
Q3 2020

Nov 17, 2020

BUY
$7.96 - $12.42 $42,944 - $67,005
5,395 Added 14.9%
41,614 $339,000
Q1 2020

May 13, 2020

BUY
$4.91 - $14.7 $2,047 - $6,129
417 Added 1.16%
36,219 $246,000
Q4 2019

Feb 14, 2020

SELL
$9.77 - $15.66 $2,803 - $4,494
-287 Reduced 0.8%
35,802 $533,000
Q2 2019

Aug 14, 2019

BUY
$9.54 - $14.96 $344,289 - $539,891
36,089 New
36,089 $383,000

Others Institutions Holding EIGR

About Eiger BioPharmaceuticals, Inc.


  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $490M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.